The popularity of PubMed allows for the collection of vast amounts of usage data, and for the intelligent use of that data to improve the search experience.
The medicines and technologies being developed – to address the pandemic and the social wreckage it is leaving in its wake – are all protectable by IP and are critically important to start to get this thing behind us, or at least to progress towards caging the beast.
Our colleague, Darren Gillgrass, recently wrote a short article entitled “Challenges in the Evolving CME Landscape.” It was selected for publication in the Journal of European CME (Continuing Medical Education). This high-impact journal is published by Taylor and Francis.
Could the velocity of scholarly content published be a measure of innovation in the fight against Coronavirus infections?
If you are considering using figures or graphics from a publication and are wondering if you need permission to include them, this blog post will help.
When you’re working in a fast-paced, but small life science company, there’s a chance your organization hasn’t thought about a copyright policy (yet.) Here’s why you need one.
Text mining in action: Learn how Eli Lilly and Georgetown University use Natural Language Processing to analyze relationships between publication volume and drug development success, and make patient care decisions.